These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3830212)

  • 1. Response to monoclonal antibodies in melanoma: specific or non-specific?
    Knuth A
    Eur J Cancer Clin Oncol; 1986 Nov; 22(11):1285-8. PubMed ID: 3830212
    [No Abstract]   [Full Text] [Related]  

  • 2. Melanoma: the development of immunoconjugates from a preclinical viewpoint.
    Beaumier PL; Morgan AC; Woodhouse CS; Marchitto KS
    Immunol Ser; 1990; 53():297-316. PubMed ID: 2100562
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of human metastatic melanoma with mouse monoclonal antibodies against GD3 ganglioside.
    Houghton AN; Bajorin DF; Lonberg M; Chapman P
    Prog Clin Biol Res; 1989; 288():383-90. PubMed ID: 2654956
    [No Abstract]   [Full Text] [Related]  

  • 4. Immune and nonimmune effector functions of IgG3 mouse monoclonal antibody R24 detecting the disialoganglioside GD3 on the surface of melanoma cells.
    Welt S; Carswell EA; Vogel CW; Oettgen HF; Old LJ
    Clin Immunol Immunopathol; 1987 Nov; 45(2):214-29. PubMed ID: 3665201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-clinical models for immunotherapy of melanoma.
    Reisfeld RA
    Prog Clin Biol Res; 1989; 288():183-93. PubMed ID: 2654950
    [No Abstract]   [Full Text] [Related]  

  • 6. Human tumor antigens.
    Reisfeld RA; Cheresh DA
    Adv Immunol; 1987; 40():323-77. PubMed ID: 3591561
    [No Abstract]   [Full Text] [Related]  

  • 7. [Anti-ganglioside monoclonal antibodies possess strong anti-tumor activities].
    Tai T
    Seikagaku; 1987 Sep; 59(9):1031-4. PubMed ID: 3437166
    [No Abstract]   [Full Text] [Related]  

  • 8. Disialoganglioside GD3 on human melanoma serves as a relevant target antigen for monoclonal antibody-mediated tumor cytolysis.
    Cheresh DA; Honsik CJ; Staffileno LK; Jung G; Reisfeld RA
    Proc Natl Acad Sci U S A; 1985 Aug; 82(15):5155-9. PubMed ID: 3860849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A monosialoganglioside is a monoclonal antibody-defined antigen of colon carcinoma.
    Magnani JL; Brockhaus M; Smith DF; Ginsburg V; Blaszczyk M; Mitchell KF; Steplewski Z; Koprowski H
    Science; 1981 Apr; 212(4490):55-6. PubMed ID: 7209516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Approaches to augmenting the IgG antibody response to melanoma ganglioside vaccines.
    Livingston PO
    Ann N Y Acad Sci; 1993 Aug; 690():204-13. PubMed ID: 8368739
    [No Abstract]   [Full Text] [Related]  

  • 11. Mouse monoclonal IgG3 antibody detecting GD3 ganglioside: a phase I trial in patients with malignant melanoma.
    Houghton AN; Mintzer D; Cordon-Cardo C; Welt S; Fliegel B; Vadhan S; Carswell E; Melamed MR; Oettgen HF; Old LJ
    Proc Natl Acad Sci U S A; 1985 Feb; 82(4):1242-6. PubMed ID: 3883355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies to 125 kd and 95 kd proteins on human melanoma cells: comparison with other monoclonal-defined melanoma antigens.
    Saxton RE; Mann BD; Morton DL; Burk MW
    Hybridoma; 1982; 1(4):433-45. PubMed ID: 6208138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanoma antibodies: specificity and interaction with melanoma and cytotoxic T-cells.
    Dippold WG; Knuth A; Meyer zum Büschenfelde KH
    Behring Inst Mitt; 1984 May; (74):14-8. PubMed ID: 6332614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of human IgG1 monoclonal antibody against gangliosides expressed on tumor cells.
    Mukerjee S; Nasoff M; McKnight M; Glassy M
    Hybridoma; 1998 Apr; 17(2):133-42. PubMed ID: 9627053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human monoclonal antibody to ganglioside GD2-inhibited human melanoma xenograft.
    Katano M; Jien M; Irie RF
    Eur J Cancer Clin Oncol; 1984 Aug; 20(8):1053-9. PubMed ID: 6540688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human monoclonal antibody to tumor-associated ganglioside GD2.
    Katano M; Saxton RE; Irie RF
    J Clin Lab Immunol; 1984 Nov; 15(3):119-26. PubMed ID: 6099419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Native and genetically engineered anti-disialoganglioside monoclonal antibody treatment of melanoma.
    Albertini MR; Hank JA; Sondel PM
    Cancer Chemother Biol Response Modif; 2005; 22():789-97. PubMed ID: 16110641
    [No Abstract]   [Full Text] [Related]  

  • 18. Tumor gangliosides as targets for active specific immunotherapy of melanoma in man.
    Morton DL; Ravindranath MH; Irie RF
    Prog Brain Res; 1994; 101():251-75. PubMed ID: 8029455
    [No Abstract]   [Full Text] [Related]  

  • 19. An epitope common to gangliosides O-acetyl-GD3 and GD3 recognized by antibodies in melanoma patients after active specific immunotherapy.
    Ravindranath MH; Morton DL; Irie RF
    Cancer Res; 1989 Jul; 49(14):3891-7. PubMed ID: 2472199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of diagnostic application of monoclonal antibody on survival in melanoma patients.
    Bender H; Grapow M; Schomburg A; Reinhold U; Biersack HJ
    Hybridoma; 1997 Feb; 16(1):65-8. PubMed ID: 9085131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.